News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MaxCyte, Inc. Presents Large Scale Flow Electroporation for Process Development and Bioproduction at CHI’s 2013 BioProcessing Summit



8/19/2013 9:24:46 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is hosting a series of events at Cambridge Health Institute’s BioProcessing Summit to be held August 19-23, 2013, at the Renaissance Boston Waterfront Hotel in Boston, MA. MaxCyte will present data in a scientific podium presentation emphasizing the use of MaxCyte flow electroporation for the rapid production of antibodies and antibody-like molecules at extremely high titers, as well as high-efficiency downstream generation of stable cell lines.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES